The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Clinical trial NCT05436418 · RECRUITING
Trial details
- NCT number
- NCT05436418
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-18
- Primary completion
- 2027-06-25
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.